Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Company Presents New 4-Year Data from the Long-Term Extensions of the BENEFIT and BENEFIT-EXT Clinical Trials of NULOJIX®(belatacept)
6/5/2012
-
Bristol-Myers Squibb Company Immune Drug Shows Promise in Three Cancers, Success May Spur Industry Race
6/5/2012
-
Bristol-Myers Squibb Company to Take Part in the Goldman, Sachs & Co. 33rd Annual Global Healthcare Conference
6/1/2012
-
Bristol-Myers Squibb Company Drug Seen Helping Body Attack Lung Cancer
5/31/2012
-
Bristol-Myers Squibb Company Forms Global Academic Cancer Collaborations
5/30/2012
-
Bristol-Myers Squibb Company to Take Part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference
5/24/2012
-
Bristol-Myers Squibb Company Ups Investment in China R&D and Manufacturing
5/17/2012
-
Bristol-Myers Squibb Company Exec Writes Book for Punishment
5/17/2012
-
Bristol-Myers Squibb Company' Plavix's New Generic Status Could be Boon for Patients
5/16/2012
-
U.S. FDA Approves Bristol-Myers Squibb Company Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)
5/15/2012
-
Bristol-Myers Squibb Company to Present New Data on 18 Abstracts on ORENCIA (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
5/15/2012
-
Bristol-Myers Squibb Company Release: Former Pro Football Coach Bill Cowher Teams Up with Leading Advocacy Groups to Launch Melanoma Exposed™, an Educational Campaign to Raise Awareness of the Most Deadly Form of Skin Cancer
5/15/2012
-
Bristol-Myers Squibb Company and Tsinghua University Enter Strategic Partnership
5/15/2012
-
Bristol-Myers Squibb Company to Present New Data on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
5/14/2012
-
Bristol-Myers Squibb Company to Present New Data on ORENCIA(R) (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
5/14/2012
-
Bristol-Myers Squibb Company to Present at Bank of America Merrill Lynch Health Care Conference
5/10/2012
-
Bristol-Myers Squibb Company Release: Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust
5/8/2012
-
Bristol-Myers Squibb Company to Present at Deutsche Bank Health Care Conference
4/30/2012
-
Could Bristol-Myers Squibb Company be a Target of Bribery?
4/27/2012
-
Bristol-Myers Squibb Company Invites Public to Listen to Webcast of 2012 Annual Meeting
4/27/2012